Skip to main content
HR 2069 114th Congress House

Neuromyelitis Optica Consortium Act

Official title: To amend the Public Health Service Act to create a National Neuromyelitis Optica Consortium to provide grants and coordinate research with respect to the cause… Show full official titleShow less

Official title: To amend the Public Health Service Act to create a National Neuromyelitis Optica Consortium to provide grants and coordinate research with respect to the causes of, and risk factors associated with, neuromyelitis optica, and for other purposes.

Introduced: April 28, 2015 See on congress.gov
Health Department of Health and Human ServicesExecutive agency funding and structureHealth programs administration and fundingHearing, speech, and vision care
More subjectsShow fewer subjects
Medical researchNational Institutes of Health (NIH)Neurological disordersResearch administration and funding
Sign in to write a letter Sign in to watch
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 1, 2015
Referred to the Subcommittee on Health.
Apr 28, 2015
Referred to the House Committee on Energy and Commerce.
Apr 28, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 1, 2015

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Neuromyelitis Optica Consortium Act

This bill amends the Public Health Service Act to require the National Institutes of Health to establish, administer, and coordinate a National Neuromyelitis Optica (NMO) Consortium to:

  • award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO (a neurological disease leading to blindness and paralysis);
  • assemble a panel of experts to provide ongoing guidance and recommendations on research design and protocols; and
  • designate a central laboratory to collect, analyze, and aggregate data from this research and to make the data and analysis available to researchers.
 Related & companion bills 1
  • HR 326 Reintroduced Bill Neuromyelitis Optica Consortium Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2069: Neuromyelitis Optica Consortium Act. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2069/
MLA
"H.R. 2069: Neuromyelitis Optica Consortium Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2069/.
Bluebook (legal)
H.R. 2069, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2069/.
Markdown link
[H.R. 2069: Neuromyelitis Optica Consortium Act](https://openamerica.io/bill/114-HR-2069/)
Report a problem